Form D · Other Health Care
HempFusion, Inc.
Sebastopol, CA · CIK 0001672324
Offering snapshot reported Aug 22, 2019 · SEC filing
- Reported sold
- $290K Offering amount: $1.1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $4K Reported outside-investor minimum
- First sale
- Aug 13, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$116,000 → $290,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2019 | Amendment | $290,000 | $174,000vs Aug 21, 2019 | 4 | SEC filing |
| Aug 21, 2019 | Initial | $116,000 | No comparison | 4 | SEC filing |
| Jun 12, 2019 | Initial | $6,000,000 | No comparison | 14 | SEC filing |
| Jan 10, 2019 | Amendment | $5,047,600 | $2,005,500vs Jun 26, 2018 | 46 | SEC filing |
| Jun 26, 2018 | Amendment | $3,042,100 | $839,400vs Apr 3, 2018 | 21 | SEC filing |
| Apr 3, 2018 | Initial | $2,202,700 | No comparison | 10 | SEC filing |
| Mar 15, 2017 | Initial | $1,020,000 | No comparison | 5 | SEC filing |
| Apr 15, 2016 | Initial | $1,194,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-347047
Total offering amount represents aggregate price of Units (232,000 Units x $1.25) plus aggregate exercise price of the Warrants comprising part of the Units (116,000 x $7, subject to adjustments). There is no guarantee that the warrants will be exercised.
Units comprised of 1 share and 1/2 warrant. Each whole warrant is exercisable at $7/share until the earlier of (i) 36 months from date of listing of the Issuer's shares on a recognized stock exchange or (ii) 2/28/23, subject to certain adjustments.
Source: Form D, filed Aug 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Merrick Adlinger | Director |
| Merrick Andlinger | Director |
| Ian De Queiroz | Director, Executive |
| Ian De Querioz | Director, Executive |
| Dave Doherty | Director |
| Craig Fortin | Executive |
| Nick Grafton | Director |
| G. Scott Greenburg | Director, Executive |
| Jason Mitchell | Director, Executive |
| Andrew Oliver | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
708 Gravenstein Highway N. Suite 188
Sebastopol, CA, 95472
Sebastopol, CA, 95472